Two-dye based arrayed primer extension for simultaneous multigene detection in lipid metabolism

Cardiovascular disease (CVD) is one of the major causes of death worldwide. Numerous genetic risk factors in lipid metabolism, including mutations of LDLR, APOB, and PCSK9, as well as polymorphisms of CETP and APOE, have been found to associate with CVD. In this study, a two-dye based arrayed primer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinica chimica acta 2015-03, Vol.442, p.36-43
Hauptverfasser: Jeenduang, Nutjaree, Porntadavity, Sureerut, von Nickisch-Rosenegk, Markus, Bier, Frank F., Promptmas, Chamras
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cardiovascular disease (CVD) is one of the major causes of death worldwide. Numerous genetic risk factors in lipid metabolism, including mutations of LDLR, APOB, and PCSK9, as well as polymorphisms of CETP and APOE, have been found to associate with CVD. In this study, a two-dye based arrayed primer extension (APEX) microarray assay for simultaneous multigene (LDLR, APOB, PCSK9, CETP, and APOE) detection was developed. The DNA templates, originating from 1 DNA sample of known genotype and 7 blind DNA samples, were amplified by uniplex PCR. Optimized conditions for the APEX reaction were determined to include a hybridization temperature of 55°C and a DNA template size of 50–150bp. The total assay including PCR, purification, fragmentation, APEX reaction, and image analysis could be performed in 6h. In total, 48 genotypes were identified among 8 individual DNA samples by APEX analysis. The data suggest that this APEX microarray offers a robust, fast, and versatile option for screening these genotypes in hypercholesterolemia patients. •Simultaneous multigene detection was developed using two-dye APEX microarray.•The detection system is able to determine genetic risk factors in lipid metabolism.•The APEX was optimized for screening of familial hypercholesterolemia (FH).•LDLR, APOB, and PCSK9 mutation and CETP and APOE polymorphisms were detected in FH.
ISSN:0009-8981
1873-3492
DOI:10.1016/j.cca.2015.01.005